Vixarelimab (KPL-716) is a human anti-oncostatin M (OSM) receptor beta subunit monoclonal antibody. Vixarelimab inhibits IL-31 and OSM signalling. Vixarelimab can be used in studies of inflammatory skin diseases such as atopic dermatitis and itchy nodular rash[1].
Molecular Weight:
(145.042 kDa)
Purity:
96.90
CAS Number:
[2243320-83-2]
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted